Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;116(3):325-8.
doi: 10.1007/s13760-015-0566-1. Epub 2015 Nov 17.

The sunflower cataract in Wilson's disease: pathognomonic sign or rare finding?

Affiliations

The sunflower cataract in Wilson's disease: pathognomonic sign or rare finding?

Ewa Langwińska-Wośko et al. Acta Neurol Belg. 2016 Sep.

Abstract

The presence of Kayser-Fleischer ring in patients with Wilson's disease (WD) is well documented and included in diagnostic algorithms; however, data about the occurrence of the second postulated ophthalmological sign of WD, sunflower cataract (SC), are limited and even conflicting. The aim of our study was to verify the occurrence of SC in WD. From January 2010 to May 2015, 81 consecutive, newly diagnosed WD patients underwent detailed ophthalmological examinations, including slit lamp examination with special attention to lens transparency, to verify the presence of SC in WD-naive patients. SC was detected in only one (1.2 %) of the examined WD patients, did not impact visual acuity; moreover, completely disappeared following a year of treatment for WD. SC may be a very rare and reversible ophthalmological manifestation of WD that is observed seldom and only at the time of WD diagnosis. We postulate that a finding of SC in WD patients is an interesting finding that may occur in the course of WD, but it is not a pathognomonic sign of WD.

Keywords: Kayser–Fleischer ring; Lens; Sunflower cataract; Wilson’s disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Sunflower cataract (SC) seen with slit lamp at time of WD diagnosis

References

    1. European Association for the Study of the Liver EASL clinical practice guidelines: Wilson’s disease. J Hepatol. 2012;56(3):671–685. doi: 10.1016/j.jhep.2011.11.007. - DOI - PubMed
    1. Dusek P, Litwin T, Czlonkowska A. Wilson disease and other neurodegenerations with metal accumulations. Neurol Clin. 2015;33(1):175–204. doi: 10.1016/j.ncl.2014.09.006. - DOI - PubMed
    1. Litwin T, Gromadzka G, Czlonkowska A. Gender differences in Wilson’s disease. J Neurol Sci. 2012;312(1–2):31–35. doi: 10.1016/j.jns.2011.08.028. - DOI - PubMed
    1. Pfeiffer R. Wilson’s disease. Semin Neurol. 2007;27(2):123–132. doi: 10.1055/s-2007-971173. - DOI - PubMed
    1. Bandmann O, Weiss KH, Kaler SG. Wilson’s disease and other neurological copper disorders. Lancet. 2015;14(1):103–113. doi: 10.1016/S1474-4422(14)70190-5. - DOI - PMC - PubMed

LinkOut - more resources